Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Craniopharyngeal duct: a cause of recurrent meningitis.

BJR case reports·2018
Same author

Management of paediatric tuberculosis in leading UK centres: unveiling consensus and discrepancies.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2014
Same author

Outpatient anti-epileptic drug prescribing errors in a Children's Hospital: an audit and literature review.

Seizure·2014
Same author

The effect of head movement on CT perfusion summary maps: simulations with CT hybrid phantom data.

Medical & biological engineering & computing·2013
Same author

Head movement during CT brain perfusion acquisition of patients with suspected acute ischemic stroke.

European journal of radiology·2013
Same author

North West England Perinatal and Paediatric HIV Network review of local guidelines used to manage infants born to HIV-positive women.

HIV medicine·2012

Related Experiment Video

Updated: Jun 29, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Update on antiretroviral therapy.

A Riordan1, T Bugembe

  • 1Department of Paediatric Infectious Diseases, Alder Hey Children's NHS Foundation Trust, Liverpool, UK. andrew.riordan@alderhey.nhs.uk

Archives of Disease in Childhood
|October 8, 2008
PubMed
Summary

Combination antiretroviral treatment (cART) effectively prevents mother-to-child HIV transmission and improves outcomes in children. Ongoing research is crucial for optimizing pediatric cART regimens, focusing on dosing, adherence, and minimizing toxicity for long-term management.

More Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Related Experiment Videos

Last Updated: Jun 29, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pharmacology

Background:

  • Combination antiretroviral treatment (cART) significantly reduces HIV transmission from mothers to children.
  • cART has proven effective in lowering mortality and morbidity rates among children living with HIV.
  • Current recommendations support cART for all HIV-infected infants and select older children.

Purpose of the Study:

  • To evaluate the long-term efficacy and safety of cART in children with HIV.
  • To identify optimal cART strategies that minimize virological failure, drug resistance, and toxicity in pediatric populations.
  • To guide the development of appropriate pediatric antiretroviral drug dosing and management protocols.

Main Methods:

  • Review of current clinical guidelines and research on pediatric HIV treatment.
  • Analysis of data on the effectiveness of various cART regimens in children.
  • Assessment of challenges related to pediatric antiretroviral drug adherence and potential drug interactions.

Main Results:

  • cART is a cornerstone in managing pediatric HIV infection, offering substantial survival benefits.
  • The availability of new antiretroviral drugs necessitates further research into pediatric-specific dosing and safety profiles.
  • Potential drug interactions, such as ritonavir and inhaled fluticasone, require careful consideration in co-administered therapies.

Conclusions:

  • Continued research is essential to refine pediatric cART regimens for lifelong management.
  • Optimizing dosing, improving adherence, and monitoring for toxicity and drug interactions are critical for successful long-term HIV care in children.
  • Further studies are needed to ensure the safe and effective use of evolving antiretroviral therapies in pediatric populations.